Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Peptide Fragments/cerebrospinal fluid/genetics"'
Autor:
Wiesje M. van der Flier, Eckart Rüther, Henne Holstege, Johannes Kornhuber, Jens Wiltfang, Charlotte E. Teunissen, Alison Goate, Piotr Lewczuk, Carlos Cruchaga, David Ramonet, Frank Jessen, Markus M. Nöthen, Oliver Peters, Michael T. Heneka, Adam C. Naj, Markus P. Kummer, Christine Herold, Heike Kölsch, R. Heun, Wolfgang Maier, Philip Scheltens, Lutz Frölich, Amy Gerrish, Julius Popp, Vincent Chouraki, Céline Bellenguez, Alzheimer's Disease Neuroimaging Initiative, Dmitriy Drichel, Tim Becker, Lara Buscemi, André Lacour, Monique M.B. Breteler, Stefan Herms, Michael Hüll, Stefanie Heilmann, Alfredo Ramirez, Per Hoffmann, Eva Louwersheimer
Publikováno v:
Human Molecular Genetics, Vol. 23, No 24 (2014) pp. 6644-6658
Ramirez, A, van der Flier, W M, Herold, C, Ramonet, D, Heilmann, S, Lewczuk, P, Popp, J, Lacour, A, Drichel, D, Louwersheimer, E, Kummer, M P, Cruchaga, C, Hoffmann, P, Teunissen, C E, Holstege, H, Kornhuber, J, Peters, O, Naj, A C, Chouraki, V, Bellenguez, C, Gerrish, A, Heun, R, Frolich, L, Hull, M, Buscemi, L, Herms, S, Kolsch, H, Scheltens, P, Breteler, M M, Ruther, E, Wiltfang, J, Goate, A, Jessen, F, Maier, W, Heneka, M T, Becker, T & Nothen, M M 2014, ' SUCLG2 identified as both a determinator of CSF Abeta1-42 levels and an attenuator of cognitive decline in Alzheimer's disease ', Human Molecular Genetics, vol. 23, no. 24, pp. 6644-6658 . https://doi.org/10.1093/hmg/ddu372
Human molecular genetics 23(24), 6644-6658 (2014). doi:10.1093/hmg/ddu372
Human Molecular Genetics, 23(24), 6644-6658. Oxford University Press
Ramirez, A, van der Flier, W M, Herold, C, Ramonet, D, Heilmann, S, Lewczuk, P, Popp, J, Lacour, A, Drichel, D, Louwersheimer, E, Kummer, M P, Cruchaga, C, Hoffmann, P, Teunissen, C E, Holstege, H, Kornhuber, J, Peters, O, Naj, A C, Chouraki, V, Bellenguez, C, Gerrish, A, Heun, R, Frolich, L, Hull, M, Buscemi, L, Herms, S, Kolsch, H, Scheltens, P, Breteler, M M, Ruther, E, Wiltfang, J, Goate, A, Jessen, F, Maier, W, Heneka, M T, Becker, T & Nothen, M M 2014, ' SUCLG2 identified as both a determinator of CSF Abeta1-42 levels and an attenuator of cognitive decline in Alzheimer's disease ', Human Molecular Genetics, vol. 23, no. 24, pp. 6644-6658 . https://doi.org/10.1093/hmg/ddu372
Human molecular genetics 23(24), 6644-6658 (2014). doi:10.1093/hmg/ddu372
Human Molecular Genetics, 23(24), 6644-6658. Oxford University Press
Cerebrospinal fluid amyloid-beta 1-42 (Aβ1-42) and phosphorylated Tau at position 181 (pTau181) are biomarkers of Alzheimer's disease (AD). We performed an analysis and meta-analysis of genome-wide association study data on Aβ1-42 and pTau181 in AD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e0346a024e4af22aa36d41fa2a4beaf
http://doc.rero.ch/record/296237/files/ddu372.pdf
http://doc.rero.ch/record/296237/files/ddu372.pdf
